FPH Share Price

Open 13.20 Change Price %
High 13.30 1 Day 0.05 0.38
Low 13.12 1 Week 0.00 0.00
Close 13.30 1 Month 0.48 3.74
Volume 1188064 1 Year 4.14 45.20
52 Week High 13.49
52 Week Low 8.13
FPH Important Levels
Resistance 2 13.47
Resistance 1 13.40
Pivot 13.24
Support 1 13.20
Support 2 13.13
NZE NewZealand Most Active Stocks
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
PGW 0.56 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
DIL 7.03 0.00%
DIL 7.03 0.00%
More..
NZE NewZealand Top Gainers Stocks
PEB 0.38 11.76%
PEB 0.38 11.76%
PEB 0.38 11.76%
CAV 0.44 10.00%
CAV 0.44 10.00%
JWI 0.45 9.76%
MGL 0.36 2.86%
MGL 0.36 2.86%
TTK 0.80 2.56%
TTK 0.80 2.56%
More..
NZE NewZealand Top Losers Stocks
ATM 7.94 -8.42%
ATM 7.94 -8.42%
ATM 7.94 -8.42%
ATM 7.94 -8.42%
SPY 0.22 -8.33%
SPY 0.22 -8.33%
SPY 0.22 -8.33%
CVT 8.00 -5.99%
CVT 8.00 -5.99%
FBU 7.09 -3.67%
More..

Fisher & Paykel Healthcar (NZE: FPH)

FPH Technical Analysis 5
As on 1st Nov 2017 FPH Share Price closed @ 13.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 10.45 & Strong Buy for SHORT-TERM with Stoploss of 12.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
FPH Target for December
1st Target up-side 13.83
2nd Target up-side 14.23
3rd Target up-side 14.64
1st Target down-side 12.67
2nd Target down-side 12.27
3rd Target down-side 11.86
FPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.fphcare.com
FPH Address
FPH
15 Maurice Paykel Place
East Tamaki
Auckland, 2013
New Zealand
Phone: 64 9 574 0100
Fax: 64 9 574 0158
FPH Latest News
Interactive Technical Analysis Chart Fisher & Paykel Healthcar ( FPH NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Fisher & Paykel Healthcar
FPH Business Profile
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, and markets medical device products and systems for use in respiratory and acute care, and the treatment of obstructive sleep apnea (OSA). The company offers a range of continuous positive airway pressure (CPAP) devices, masks, and humidifiers, which comprise nasal, full face, and oral masks. It also provides respiratory humidifiers, single-use and reusable chambers and breathing circuits and accessories designed to humidify and deliver the gases that a patient receives during mechanical ventilation, non-invasive ventilation, oxygen therapy, humidity therapy and laparoscopic surgery; and T-piece resuscitation, invasive ventilation, CPAP therapy, nasal high flow, and low flow therapy solutions for infants. In addition, the company offers humidification systems for preventing unnecessary cellular damage by protecting tissue against the harmful effects of cold, dry carbon dioxide2; and protecting the peritoneum against damage caused by cold, dry surgical gas during laparoscopic surgery. Fisher & Paykel Healthcare Corporation Limited sells its products through its distribution subsidiaries, third party distributors, and original equipment manufacturers in New Zealand, North America, Europe, and the Asia-Pacific. The company was founded in 1934 and is headquartered in Auckland, New Zealand.